Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1037389 NEW YORK, NY
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,119,182
+$10,146,546 QoQ
Shares Held
768,600
+278.4% QoQ
Ownership
0.678%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#41
of 215 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. VRDN ranks #41 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in VRDN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,119,182 768,600
2026-03-31 $3,972,636 203,100
2025-03-31 $4,317,644 320,300
2024-12-31 $7,115,904 371,200
2024-09-30 $1,355,900 59,600
2024-06-30 $3,221,276 247,600
2024-03-31 $4,582,367 261,700
2023-12-31 $291,852 13,400
2023-09-30 $1,000,168 65,200
2023-06-30 $1,808,040 76,000
2023-03-31 $910,752 35,800
2022-09-30 $2,083,816 101,600
2021-03-31 $221,240 13,240